Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2012
12/27/2012WO2012175633A1 Efficient induction of definitive endoderm from pluripotent stem cells
12/27/2012WO2012175598A1 Method for activation of specific peripheral blood mononuclear cells
12/27/2012WO2012149484A3 Method of cryopreservation of stem cell-derived retinal pigment epithelial cells on polymeric substrate
12/27/2012WO2012141657A8 A method of identifying, isolating and/or culturing foetal erythroblasts
12/27/2012WO2012134215A3 Expression vector for animal cells
12/27/2012WO2012125955A3 Methods and materials for prolonging useful storage of red blood cell preparations and platelet preparations
12/27/2012WO2012122015A3 Selective inhibitors of tumor-initiating cells
12/27/2012WO2012116274A3 Genetically modified animals and methods for making the same
12/27/2012WO2012112982A3 Hydrogel encapsulated cells and anti-inflammatory drugs
12/27/2012WO2006003215A9 Targeted transgenesis of short hairpin rna expression cassettes using recombinase mediated cassette exchange
12/27/2012US20120331590 Use of cry1da in combination with cry1be for management of resistant insects
12/27/2012US20120331589 COMBINED USE OF CRY1Da AND CRY1Fa PROTEINS FOR INSECT RESISTANCE MANAGEMENT
12/27/2012US20120331588 Polypeptides Having Endoglucanase Activity And Polynucleotides Encoding Same
12/27/2012US20120331586 Plants having enhanced yield - related traits and a method for making the same
12/27/2012US20120331585 Plants having enhanced yield-related traits and a method for making the same
12/27/2012US20120331584 Plants having enhanced yield-related traits and a method for making the same
12/27/2012US20120331583 Modulating plant oil levels
12/27/2012US20120331581 Polynucleotides and polypeptides involved in post-transcriptional gene silencing
12/27/2012US20120331580 Mutant hydroxyphenylpyruvate dioxygenase polypeptides and methods of use
12/27/2012US20120331578 Method for Producing Recombinant Glycoproteins Having Beta1,2-Bound Xylose Residues
12/27/2012US20120331577 Lettuce variety 79-163 rz
12/27/2012US20120331576 Pathogen Restriction Factors
12/27/2012US20120331574 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
12/27/2012US20120331573 DYNACTIN SUBUNIT p62 BIOMARKER FOR NEUROLOGICAL CONDITIONS
12/27/2012US20120329997 Antibodies against human csf-1r and uses thereof
12/27/2012US20120329990 B7-related nucleic acids and polypeptides useful for immunomodulation
12/27/2012US20120329882 pH Responsive Self-Heating Hydrogels Formed By Boronate-Catechol Complexation
12/27/2012US20120329879 Beta-adrenergic receptor agonists and uses thereof
12/27/2012US20120329865 MOLECULES RELATED hERG ION CHANNELS AND THE USE THEREOF
12/27/2012US20120329861 Treatment of cancer using benzoic acid derivatives
12/27/2012US20120329858 Modified oligonucleotides for telomerase inhibition
12/27/2012US20120329857 Short Hairpin RNAs for Inhibition of Gene Expression
12/27/2012US20120329856 Methods And Compositions For Reducing Viral Genome Amounts In A Target Cell
12/27/2012US20120329855 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf
12/27/2012US20120329838 Novel modulators of sphingosine phosphate receptors
12/27/2012US20120329836 Methods for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer
12/27/2012US20120329800 Treatment of muscular dystrophies and associated conditions by administration of monoamine oxidase inhibitors
12/27/2012US20120329786 Compounds and therapeutic uses thereof
12/27/2012US20120329783 Compositions and methods for selective inhibition of nicotine acetylcholine receptors
12/27/2012US20120329776 Heterocyclic compounds and uses thereof
12/27/2012US20120329761 Use of tigecycline for treatment of cancer
12/27/2012US20120329748 Activation and activators of sirt5
12/27/2012US20120329733 Methods and products related to metabolic interactions in disease
12/27/2012US20120329727 Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense transcript to ucp2
12/27/2012US20120329720 Anti-inflammatory compounds and uses thereof
12/27/2012US20120329717 Novel omega conotoxin peptides
12/27/2012US20120329714 Prolactin Induced Increase in Neural Stem Cell Numbers
12/27/2012US20120329710 Methods of Inducing Regulated Pancreatic Hormone Production in Non-Pancreatic Islet Tissues
12/27/2012US20120329709 Production of glycoproteins
12/27/2012US20120329679 Eukaryotic cell display systems
12/27/2012US20120329671 Methods of identifying obm modulators
12/27/2012US20120329159 Down-Regulation Of Gene Expression Using Artificial MicroRNAs
12/27/2012US20120329158 Methods of Plant Regeneration and Apparatus Therefor
12/27/2012US20120329157 Cell construct comprising polymer blocks having biocompatibility and cells
12/27/2012US20120329156 Three-dimensional scaffold and method of manufacturing the same
12/27/2012US20120329155 Medium for mammalian somatic cells and additive therefor
12/27/2012US20120329154 Macrophage phagocytosis-activating composition and/or composition promoting cytokine production in macrophages
12/27/2012US20120329153 Car receptor as a mediator of migratory cell chemotaxis and/or chemokinesis
12/27/2012US20120329152 Induction, propagation and isolation of liver progenitor cells
12/27/2012US20120329151 Method of culturing eukaryotic cells
12/27/2012US20120329150 Methods and compositions for expressing negative-sense viral rna in canine cells
12/27/2012US20120329149 Humanized antibody
12/27/2012US20120329126 Hybrid polymerases having the ability to produce long amplicons
12/27/2012US20120329125 Group culture system and method with helper embryos
12/27/2012US20120329094 Anti-CD22 Antibodies And Immunoconjugates and Methods of Use
12/27/2012US20120329093 Polynucleotides encoding antibodies that bind both il-17a and il-17f
12/27/2012US20120329087 Cell preparation containing mesenchymal stem cells, and method for producing same
12/27/2012US20120329067 Methods of Generating Zinc Finger Nucleases Having Altered Activity
12/27/2012US20120329063 Novel means for the diagnosis and therapy of ctcl
12/27/2012US20120329052 Identification of a dna variant associated with adult type hypolactasia
12/27/2012US20120329035 Methods for improving sperm functionality
12/27/2012US20120329034 Method For Producing An Acellular Dermal Matrix, And Acellular Dermal Matrix Produced By Same
12/27/2012US20120328764 Lettuce variety 79-190 or 79-107 rz
12/27/2012US20120328712 Carbon monoxide releasing rhenium compounds for medical use
12/27/2012US20120328668 Modified sirna molecules and uses thereof
12/27/2012US20120328665 Composite nanoparticle, and preparation process and use thereof
12/27/2012US20120328662 Composition for inhibiting tumor cell proliferation
12/27/2012US20120328651 Chimpanzee adenovirus vaccine carriers
12/27/2012US20120328650 Modified vaccinia ankara virus variant
12/27/2012US20120328641 Conformationally stabilized hiv envelope immunogens
12/27/2012US20120328638 Mybl2 peptides and vaccines containing the same
12/27/2012US20120328637 Methods and compositions for modulating the activity of the interleukin-35 receptor complex
12/27/2012US20120328633 T cell activation inhibitor, pharmaceutical composition containing same, and screening method for t cell activation inhibiting substance
12/27/2012US20120328629 Therapeutic Applications Targeting SARM1
12/27/2012US20120328626 Method for increasing n-glycosylation site occupancy on therapeutic glycoproteins produced in pichia pastoris
12/27/2012US20120328620 Epidermalgrowth factor receptor mutations
12/27/2012US20120328616 Human antigen binding proteins that bind to a complex comprising beta-klotho and an fgf receptor
12/27/2012US20120328613 Humanized anti-factor d antibodies and uses thereof
12/27/2012US20120328612 Anti-flt3 antibodies and methods of using the same
12/27/2012US20120328599 Inhibitors of receptor tyrosine kinases (rtk) and methods of use thereof
12/27/2012US20120328587 Method for Activating Natural Killer Cells by Tumor Cell Preparation In Vitro
12/27/2012US20120328584 Biological Pacemaker
12/27/2012US20120328582 Primate Embryonic Stem Cells
12/27/2012US20120328581 Tissue repair
12/27/2012US20120328580 Compounds that enhance atoh1 expression
12/27/2012US20120328579 Human trophoblast stem cells and use thereof
12/27/2012US20120328565 Antiviral compounds
12/27/2012US20120328563 Cd4+cd25+ regulatory t cells from human blood
12/27/2012US20120328524 Anti-gd2 antibodies and methods and uses related thereto
12/27/2012US20120328523 Polyhydroxyalkanoates for in vivo applications
1 ... 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 ... 1827